196 related articles for article (PubMed ID: 32445444)
21. Molecular Mechanisms of Antiviral Agents against Dengue Virus.
Lee MF; Wu YS; Poh CL
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992414
[TBL] [Abstract][Full Text] [Related]
22. Discovery of conjugated thiazolidinone-thiadiazole scaffold as anti-dengue virus polymerase inhibitors.
Manvar D; Küçükgüzel İ; Erensoy G; Tatar E; Deryabaşoğulları G; Reddy H; Talele TT; Cevik O; Kaushik-Basu N
Biochem Biophys Res Commun; 2016 Jan; 469(3):743-7. PubMed ID: 26697747
[TBL] [Abstract][Full Text] [Related]
23. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.
Cannalire R; Tarantino D; Astolfi A; Barreca ML; Sabatini S; Massari S; Tabarrini O; Milani M; Querat G; Mastrangelo E; Manfroni G; Cecchetti V
Eur J Med Chem; 2018 Jan; 143():1667-1676. PubMed ID: 29137867
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
25. Challenges and Perspectives in the Discovery of Dengue Virus Entry Inhibitors.
Gallo FN; Enderle AG; Pardo LA; Leal ES; Bollini M
Curr Med Chem; 2022; 29(4):719-740. PubMed ID: 34036904
[TBL] [Abstract][Full Text] [Related]
26. A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2.
Punekar M; Kasabe B; Patil P; Kakade MB; Parashar D; Alagarasu K; Cherian S
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298705
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp.
Coulerie P; Nour M; Maciuk A; Eydoux C; Guillemot JC; Lebouvier N; Hnawia E; Leblanc K; Lewin G; Canard B; Figadère B
Planta Med; 2013 Sep; 79(14):1313-8. PubMed ID: 23929244
[TBL] [Abstract][Full Text] [Related]
28. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
29. Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase.
Coulerie P; Eydoux C; Hnawia E; Stuhl L; Maciuk A; Lebouvier N; Canard B; Figadère B; Guillemot JC; Nour M
Planta Med; 2012 May; 78(7):672-7. PubMed ID: 22411725
[TBL] [Abstract][Full Text] [Related]
30. The dengue virus NS5 protein as a target for drug discovery.
Lim SP; Noble CG; Shi PY
Antiviral Res; 2015 Jul; 119():57-67. PubMed ID: 25912817
[TBL] [Abstract][Full Text] [Related]
31. An adenosine nucleoside inhibitor of dengue virus.
Yin Z; Chen YL; Schul W; Wang QY; Gu F; Duraiswamy J; Kondreddi RR; Niyomrattanakit P; Lakshminarayana SB; Goh A; Xu HY; Liu W; Liu B; Lim JY; Ng CY; Qing M; Lim CC; Yip A; Wang G; Chan WL; Tan HP; Lin K; Zhang B; Zou G; Bernard KA; Garrett C; Beltz K; Dong M; Weaver M; He H; Pichota A; Dartois V; Keller TH; Shi PY
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20435-9. PubMed ID: 19918064
[TBL] [Abstract][Full Text] [Related]
32. Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection.
Yao X; Guo S; Wu W; Wang J; Wu S; He S; Wan Y; Nandakumar KS; Chen X; Sun N; Zhu Q; Liu S
J Pharmacol Sci; 2018 Dec; 138(4):247-256. PubMed ID: 30518482
[TBL] [Abstract][Full Text] [Related]
33. Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue.
Amraiz D; Zaidi NU; Fatima M
Enzyme Microb Technol; 2016 Oct; 92():26-30. PubMed ID: 27542741
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological intervention for dengue virus infection.
Lai JH; Lin YL; Hsieh SL
Biochem Pharmacol; 2017 Apr; 129():14-25. PubMed ID: 28104437
[TBL] [Abstract][Full Text] [Related]
36. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
[TBL] [Abstract][Full Text] [Related]
37. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.
Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F
PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489
[TBL] [Abstract][Full Text] [Related]
38. Infection of Aedes albopictus Mosquito C6/36 Cells with the
Teramoto T; Huang X; Armbruster PA; Padmanabhan R
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
[TBL] [Abstract][Full Text] [Related]
39. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
[TBL] [Abstract][Full Text] [Related]
40. Interference of dengue replication by blocking the access of 3' SL RNA to the viral RNA-dependent RNA polymerase.
Tunghirun C; Narkthong V; Chaicumpa W; Chimnaronk S
Antiviral Res; 2020 Oct; 182():104921. PubMed ID: 32835694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
